Concepedia

A. Berrier

AB

Statistics

Publications

3

Citations

154

H-Index

3

Active since

2010

Affiliations

Centre Hospitalier de Lens(Current)

A. Berrier is an author at Centre Hospitalier de Lens specializing in oncology pharmacotherapy, study phase, and chemotherapy.

Publications per year

2010–2016

3

Publications

3

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Kevin J. Harrington, A. Berrier, Martin Robinson et al. · European Journal of Cancer · 2012 · 118 citations

, , +7

Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN).

Kevin J. Harrington, A. Berrier, Max Robinson et al. · Journal of Clinical Oncology · 2010 · 26 citations

, , +11

Observational study of the cetuximab relative dose intensity (RDI) in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Data on the maintenance and every two weeks use (DIRECT study)

J. Guigay, Emmanuel Chamorey, P. Céruse et al. · Annals of Oncology · 2016 · 10 citations

, , +10

1–3 of 3